Ipsapirone
| Ipsapirone | |
|---|---|
| Salts [] | |
|---|---|
| Ipsapirone hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 401.50 g/mol [1] |
| Predicted LogP | 1.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C19H23N5O3S |
| IUPAC name | 1,1-dioxo-2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,2-benzothiazol-3-one |
| SMILES | C1CN(CCN1CCCCN2C(=O)C3=CC=CC=C3S2(=O)=O)C4=NC=CC=N4 |
| InChI | InChI=1S/C19H23N5O3S/c25-18-16-6-1-2-7-17(16)28(26,27)24(18)11-4-3-10-22-12-14-23(15-13-22)19-20-8-5-9-21-19/h1-2,5-9H,3-4,10-15H2 |
| InChIKey | TZJUVVIWVWFLCD-UHFFFAOYSA-N |
| CAS number | 95847-70-4 |
| UNII | 6J9B11MN0K |
| PubChem CID | 56971 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | Ipsapirone: 1–3 hours, 1-PP: 6.1 hours[3][4] |
| Routes of administration | Oral |
Ipsapirone (also known as Ipsapirona, Ipsapironum, Tvx-q-7821, isapirone, 1,1-dioxo-2-(4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl)-1,2-benzothiazol-3-one, Tvx q 7821, Ccg-220609, Ipsapironum [Latin], Ipsapirona [Spanish] or C19h23n5o3s) is a substance of the benzylamine class.
Chemistry
Salts []
Ipsapirone is typically found in the form of its hydrochloride salt.
Stereochemistry []
Ipsapirone is achiral.
Druglikeness
Lipinski's rule of five
Ipsapirone matches Lipinski's rule of five.Pharmacology
MeSH Classification
Legal status []
- Other: Ipsapirone is a Uncontrolled.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 56971, Ipsapirone. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/56971
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ipsapirone. UNII: 6J9B11MN0K. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6J9B11MN0K
Fuhr U, Staib AH, Harder S, Becker K, Liermann D, Schöllnhammer G, Roed IS. Absorption of ipsapirone along the human gastrointestinal tract. Br J Clin Pharmacol. July 1994; 38(1):83–86. PMID 7946942.
Berlin I, Chalon S, Payan C, Schöllnhammer G, Cesselin F, Varoquaux O, Puech AJ. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine. Br J Clin Pharmacol. March 1995; 39(3):243–249. PMID 7619663.
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 19:00:30 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 19:00:26 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 19:00:26 |
| gsrs | ok | 2026-11-20 19:00:27 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0253573) | 2026-11-20 19:00:26 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 19:00:29 |
| pubchem | ok | 2026-11-20 19:00:26 |
| missing (no r/tripreports posts mention it) | 2026-11-20 19:00:26 | |
| sider | missing (not in SIDER) | 2026-11-20 19:00:26 |
| structure | ok | 2026-11-20 19:00:26 |
| wikipedia | ok | 2026-11-20 19:00:26 |